Riskpilot
← Back to search
Sign in
Get full access
AB Medifa
AB
Active
Org 5568010630
Björkhagsvägen 21, 756 46
Uppsala
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2010
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
AB Medifa
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
3M
3M
2020
3M
2021
2M
2022
2M
2023
3M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 590
2 600
2 426
1 762
2 791
Staff expenses
—
—
−575
−4
−8
EBITDA
764
476
208
−131
−258
Depreciation & amort.
−0
−0
—
—
—
EBIT
764
476
208
−131
−258
Net financials
—
−25
−4
−8
−2
Profit before tax
573
978
154
11
−260
Tax
−123
−207
−37
−4
—
Net profit
450
771
117
7
−260
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 229
2 482
989
800
705
Equity
1 388
2 159
480
487
227
Long-term debt
0
0
3
2
2
Short-term debt
315
323
456
311
476
Total debt
315
323
459
313
478
Financial ratios
5-year trend
EBITDA margin
-9.2%
This company
15.8%
Market median
-158% vs market
2020
2024
Equity ratio
32.2%
This company
38.2%
Market median
+16% vs market
2020
2024
Return on equity
-114.9%
This company
18.4%
Market median
-724% vs market
2020
2024
Net profit margin
-9.3%
This company
8.1%
Market median
-215% vs market
2020
2024
Asset turnover
3.96×
This company
1.12×
Market median
+254% vs market
2020
2024
Debt / equity
2.11×
This company
0.62×
Market median
-240% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF